CMV pp65 peptide NLVPMVATV (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
CMV pp65 peptide NLVPMVATV (HLA-A*0201)

CMV pp65 peptide NLVPMVATV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from human cytomegalovirus (CMV) phosphoprotein (pp65) is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: NLVPMVATV
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

HIV p24-Gag peptide KAFSPEVIPMF (HLA-B*5701)

HIV p24-Gag peptide KAFSPEVIPMF (HLA-B*5701)

IBA Lifescience
Więcej
MHC I-Strep HLA-B*0801; EBV EBNA-3A (FLRGRAYGL)

MHC I-Strep HLA-B*0801; EBV EBNA-3A (FLRGRAYGL)

IBA Lifescience
Więcej
MHC I-Strep HLA-A*0201; EBV BMLF1 (GLCTLVAML)

MHC I-Strep HLA-A*0201; EBV BMLF1 (GLCTLVAML)

IBA Lifescience
Więcej